Clinical Trial

HerResolve™ in Detecting the Presence of Endometriosis Among Symptomatic Women

Recruiting
View on ClinicalTrials.gov →
Summary
Endometriosis (EMS) is a common gynecological disease that affects 176 million girls and women globally. EMS affects 5-10% of women and adolescents within the reproductive age range of 15-49 years, and for those facing infertility, this figure may climb up to 50%. EMS can start at the first menstrual period and last until menopause. Shockingly, between 50% and 80% of women grappling with pelvic pain are found to have EMS. The formation of scar tissue (adhesions, fibrosis) within the pelvis and other parts of the body can cause severe pain and lead to infertility.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-28; most recent amendment 2025-12-02.
Status change: Not Yet Recruiting → Recruiting 2025-12-02
Trial Details
NCT Number NCT07006987
Lead Sponsor Chinese University of Hong Kong
Conditions Endometriosis
Enrollment 100 participants
Start Date 2025-10-14
Primary Completion 2030-05-31 (estimated)
Study Completion 2037-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-03